Adult Living Donor Versus Deceased Donor Liver Transplantation: A 6‐Year Single Center Experience

No long‐term (>3 years) prospective comparison of adult‐to‐adult living donor liver transplantation (A2ALLTx) to adult deceased donor liver transplantation (ADDLTx) has been reported.

[1]  J. Galanko,et al.  Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[2]  I. Kam.  Adult‐adult right hepatic lobe living donor liver transplantation for status 2a patients: Too little, too late , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[3]  I. Colle,et al.  Hepatitis C infection-related liver disease: patterns of recurrence and outcome in cadaveric and living-donor liver transplantation in adults , 2004, Transplantation.

[4]  P. Morris,et al.  The living donor. , 2003, Transplantation.

[5]  A. Marcos.  Right‐lobe living donor liver transplantation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[6]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[7]  R. Merion,et al.  Association of Center Volume with Outcome After Liver and Kidney Transplantation , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  D. Landsberg,et al.  The Living Anonymous Kidney Donor: Lunatic or Saint? , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[9]  S. Todo,et al.  Living donor liver transplantation in adults: Outcome in Japan , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[10]  R. Fisher,et al.  A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation. , 1998, Transplantation.

[11]  R. Fisher,et al.  Segmental orthotopic hepatic transplantation as a means to improve patient survival and diminish waiting-list mortality. , 1991, Journal of pediatric surgery.

[12]  Randall G. Lee,et al.  Banff schema for grading liver allograft rejection: An international consensus document , 1997, Hepatology.

[13]  J. Emond,et al.  Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[14]  V. Caron,et al.  United states. , 2018, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[15]  K. Beavers,et al.  Practice patterns for long‐term follow‐up of adult‐to‐adult right lobectomy donors at US transplantation centers , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[16]  J. Emond,et al.  Application of Reduced‐size Liver Transplants as Split Grafts, Auxiliary Orthotopic Grafts, and Living Related Segmental Transplants , 1990, Annals of surgery.

[17]  G. Everson,et al.  Adult-to-adult transplantation of the right hepatic lobe from a living donor. , 2002, The New England journal of medicine.

[18]  M. Malago',et al.  Living donor liver transplantation in adults: Outcome in Europe , 2000 .

[19]  J. Emond,et al.  Living donor liver transplantation and hepatitis C , 2004, Clinics in liver disease.

[20]  R. Merion,et al.  Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Ann Surg 1990;212:368–375 , 1991 .

[21]  R. Fisher,et al.  Single‐center analysis of the first 40 adult‐to‐adult living donor liver transplants using the right lobe , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[22]  Z. Zhang,et al.  [Comparison of acute cellular rejection between living donor liver transplantation and cadaveric liver transplantation]. , 2001, Zhonghua yi xue za zhi.

[23]  R. Fisher,et al.  Emergency portacaval shunt for control of hemorrhage from a parenchymal fracture after adult-to-adult living donor liver transplantation. , 2000, Transplantation.

[24]  U. Neumann,et al.  Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up , 2004, Transplantation.

[25]  R. Wolfe,et al.  The Survival Benefit of Liver Transplantation , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[26]  藤田 みさお.  「肝右葉切除術による成人間生体肝移植」, Trotter JF, Wachs M, Everson GT, et al, Adult-to-adult transolantation of the right hepatic lobe from a living donor, N Engl J Med 346, 1074-1082, 2002 , 2003 .